Investegate |UniVision Eng Ltd Announcements | UniVision Eng Ltd: UniVision wins invention award investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
If you re short-sighted there s a chance your child may be too.
- Credit: Getty Images/iStockphoto
Say aye to defending your child’s vision against short-sightedness and giving them the best possible future.
In a world of consoles, tablets, mobiles and social media, screen time seems an unavoidable part of growing up, which is why now, more than ever, we as parents must do all we can to help protect our child’s eyesight.
Alex Kemp, optometrist and owner of The Eye Place in Bakewell reveals how you can do just that.
Q: What is myopia?
A: Myopia, more commonly known as short-sightedness, affects how light focuses on the retina, making nearby objects appear blurry. Research suggests modern lifestyle changes could mean as many as five billion people could suffer from myopia by 2050.
BonchaBio’s Breakthrough Probiotics Candyceutical Wins Gold at Inventions Geneva
Share Article
Taipei-based biotech company BonchaBio has won Gold at the International Exhibition of Inventions Geneva 2021 (Inventions Geneva) for its breakthrough “symbiotic candyceutical” – a candy-dosage probiotics product with optimal delivery results. TAIPEI, Taiwan (PRWEB) May 05, 2021 The company’s innovative delivery technologies make it possible to retain a high amount of live bacteria in a single probiotics candyceutical – out of the original 1010 CFUs– even after production and 12 months of shelf life.
BonchaBio has developed a technology platform that optimizes nutraceutical delivery against the harsh conditions that degrade ingredients, with the world’s first low-temperature, low-pressure candy manufacturing technology.
Share this article
Share this article
BANGKOK, April 27, 2021 /PRNewswire/ HOYA Vision Care, a leader in optical technology innovation, shared the results of a three-year follow-up clinical study on its award winning MiYOSMART spectacle lens with patented Defocus Incorporated Multiple Segments (D.I.M.S.) Technology after releasing the information at the recent European Academy of Optometry and Optics (EAOO) 21 conference. The new study, published in March 2021 in the British Journal of Ophthalmology, was conducted by the Centre for Myopia Research at The Hong Kong Polytechnic University and follows-up on the two-year study which previously demonstrated evidence of the effectiveness of the lens in slowing down the progression of myopia in children ages 8-13
The University of Hong Kong (HKU), my alma mater, has reaped a total of 11 gold and silver awards as well as Gold Medal with Congratulations of the Jury in the Special Edition 2021 Inventions Geneva Evaluation Days (“Geneva Inventions Expo”). The alumni are all very excited about the good news. HKU has won numerous awards over the years. What is so special about this award?
Founded in 1972, the Geneva Inventions Expo serves as a bridge between inventors and manufacturers as well as investors, the event assists in the commercialization of scientific research results. This is precisely what Hong Kong’s academia has been criticized in the past: Despite our world-class scientific research capability, most of the research results only stay in the form of theoretical discussion inside the ivory tower. The Geneva Inventions Expo is a good stepping stone to bring research results to the world s commercial arena.